Cao Fan

Cao Fan


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2015 in Virology Journal
Verified
Journal Article
Open access
PDF file
CFCao Fan
Cao Fan
YZYing Zhang
Ying Zhang
YZYun Zhou
Yun Zhou
BLBingjie Li
Bingjie Li
YHYu He
Yu He
ZJZhansheng Jia
Zhansheng Jia
Anti-hepatitis C virus (HCV) responses are often accompanied by an increase in alanine aminotransferase levels in HCV-infected patients, indicating that inflammatory responses are compromised by the virus. Additionally, inflammation is associated with M1-polarizated macrophages, which secrete cytokines such as tumor necrosis factor-α, interleukin-1, and interleukin-12, and present antigens through phagocytosis. HCV-encoded proteins are presented as specific viral antigens in particular infectious steps that influence the immune response. For instance, HCV antigens impact macrophage PD-1 and Tim-3 expression, and contribute to impaired viral clearance. Furthermore, circulatory HCV antigens from infected patients inhibit dendritic cell differentiation, which raises the possibility that HCV antigens may also interfere with macrophage polarization. In this study, the impact of HCV antigen stimulation on M1-polarized macrophages was investigated. The influence of HCV antigens was evaluated by reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay. Specific changes were investigated clinically by flow cytometry and immunofluorescence. Effects of NF-κB during the process were analyzed by western blot. HCV infection dampened M1 macrophage polarization ex vivo and in vitro. After antigen stimulation, NF-κB signaling was suppressed by the up-regulation of A20 and A20-binding inhibitor of NF-κB binding protein, which likely leads to a variation of functional molecules such as tumor necrosis factor-α, CD163, matrix metalloproteinases, transferrin receptor-1, and CD100, reflecting an anti-inflammatory reaction against M1-polarization. HCV antigens stimulation up-regulates A20/A20-binding inhibitor of NF-κB binding protein expression, which consequently contributes to inefficient M1 macrophage polarization.

1 November 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
YZYun Zhou
Yun Zhou
PZPeixin Zhang
Peixin Zhang
XZXuyang Zheng
Xuyang Zheng
CYChuantao Ye
Chuantao Ye
MLMengyuan Li
Mengyuan Li
YZYing Zhang
Ying Zhang
MiR-155 regulates pro- and anti-inflammatory cytokine expression in human monocytes during chronic hepatitis C virus infection Yun Zhou, Peixin Zhang, Xuyang Zheng, Chuantao Ye, Mengyuan Li, Peiyu Bian, Chao Fan, Ying Zhang

12 January 2017 in Journal of International Medical Research
Verified
Journal Article
Open access
BLBing Jie Li
Bing Jie Li
YHYu He
Yu He
YZYing Zhang
Ying Zhang
YGYong Hong Guo
Yong Hong Guo
YZYun Zhou
Yun Zhou
ZJZhansheng Jia
Zhansheng Jia
Objectives: We investigated the effects of CD100 on naïve CD8+ T cells during hepatitis C virus (HCV) infection after interferon-α (IFN-α) therapy to clarify the mechanism underlying the effect of IFN-α in enhancing the antiviral response. Methods: The CD100 molecules on subsets of CD8+ T cells were analysed with flow cytometry. The effects of CD100-overexpressing naïve CD8+ T cells were determined with ELISAs and an MTT cytotoxicity assay. The role of CD100–CD72 signal transduction was analysed with a neutralization and transwell assays. Results: HCV infection reduced CD100 expression on CD8+ T cells, whereas IFN-α treatment significantly increased CD100 expression on naïve CD8+ T cells. The increased CD100 interacted with the CD72 receptor and enhanced PBMC cytokine secretion (IFN-γ and tumour necrosis factor-α) and cytotoxicity. Conclusions: IFN-α-induced CD100 on naïve CD8+ T cells promotes PBMC cytokine secretion and cytotoxicity through CD100–CD72 signalling during HCV infection.

15 November 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
SCShiqi Chai
Shiqi Chai
CYChuantao Ye
Chuantao Ye
CFCao Fan
Cao Fan
HJHong Jiang
Hong Jiang
Influenza viruses remain a major global public health concern, causing significant morbidity and mortality annually despite widespread vaccination efforts. The limitations of current seasonal vaccines, including strain-specific efficacy and manufacturing delays, have accelerated the development of next-generation candidates aiming for universal protection. This review comprehensively summarizes the recent progress in universal influenza vaccine research. We first outline the key conserved antigenic targets, such as the hemagglutinin (HA) stem, neuraminidase (NA), and matrix proteins (M2e, NP, and M1), which are crucial for eliciting broad cross-reactive immunity. We then delve into advanced antigen design strategies, including immunofocusing, multi-antigen combinations, computationally optimized broadly reactive antigens (COBRA), and nanoparticle-based platforms. Furthermore, we evaluate evolving vaccine delivery systems, from traditional inactivated and live-attenuated vaccines to modern mRNA and viral vector platforms, alongside the critical role of novel adjuvants in enhancing immune responses. The convergence of these disciplines—structural biology, computational design, and nanotechnology—is driving the field toward a transformative goal. We conclude that the successful development of a universal influenza vaccine will likely depend on the strategic integration of these innovative approaches to overcome existing immunological and logistical challenges, ultimately providing durable and broad-spectrum protection against diverse influenza virus strains.

20 September 2013 in Journal of Electronics & Information Technology
Verified
Journal Article
Closed access
CFCao Fan
Cao Fan
HOHong-Lin Ouyang
Hong-Lin Ouyang
YZYingjie Zhang
Yingjie Zhang

1 December 2018 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
XZXiaoxiao Zhang
Xiaoxiao Zhang
LYLina Yang
Lina Yang
FWFang Wang
Fang Wang
ZLZiyu Liu
Ziyu Liu
RLRongrong Liu
Rongrong Liu
XWXingan Wu
Xingan Wu
Aims: Single nucleotide polymorphisms (SNP) can be used as genetic markers and for risk assessment of allele-linked diseases, which may provide information for clinical diagnosis. Large-scale microarray and next-generation sequencing methods have made genome-wide SNP genotyping possible. However, in addition to their high cost, these techniques are dependent on having specialized equipment. Thus, there is a need for a simple genotyping method that can be implemented in a resource-limited environment. Methods: We developed a strategy for SNP genotyping based on T7 Endonuclease I cleavage and an enzyme-linked microparticle immune assay. Using this method, we genotyped two common SNP sites (rs11526468 and rs12979860). The quality of the genotyping process was validated. Results: Although a 70% false-negative rate was observed, no false-positive reactions were found. Therefore, multiple parallel repeat reactions can offset the possibility off time failed detection. Discussion: As the method employs a duplicate reagent-dependent procedure, it has the potential for integration into a portable kit for field operation.